ICU · cardiovascular
Post-Cardiac Surgery ICU Management — Comprehensive
Also known as Post-cardiac surgery ICU · Post-CABG ICU · Post-valve surgery ICU · Post-cardiopulmonary bypass · Post-CPB management · Cardiac surgical ICU · Post-sternotomy care · Vasoplegic syndrome post-CPB · Low cardiac output syndrome
Post-cardiac surgery ICU management — the systematic care of patients after cardiopulmonary bypass (CPB) surgery (CABG, valve replacement/repair, aortic surgery). The early postoperative period focuses on: (1) haemodynamic stabilisation (vasoplegic syndrome in 9-44% of bypass patients — NO-mediated distributive shock with a normal or high cardiac index — noradrenaline first, vasopressin, methylene blue 2 mg/kg for refractory; low cardiac output syndrome — dobutamine first-line), (2) bleeding and tamponade assessment (severe chest tube output over 300 mL in the first hour, over 200 in the second and over 100 in the third carries attributable harm; sudden cessation with haemodynamic collapse = clotted tube and tamponade until proven otherwise → URGENT RE-EXPLORATION, which runs at 2.5-3.7% and is safest within 4 hours), (3) rhythm management (new AF in 20-40% with onset on days 2-4 — rate control usually suffices, beta-blocker prophylaxis best established), (4) ventilatory support and weaning (fast-track: extubation within 6 hours in selected patients once warm, stable, not bleeding and awake), (5) temperature and metabolic management (rewarm — hypothermia on ICU arrival predicts bleeding and re-exploration; keep potassium and magnesium replete; tight glucose control improves diabetic CABG outcomes).
Checked against its sources on 2 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Severe chest tube bleeding (over 300 mL in the first hour, over 200 in the second, over 100 in the third) OR sudden CESSATION of drainage with haemodynamic collapse = attributable harm or clotted-tube tamponade → early URGENT RE-EXPLORATION (within 4 hours is safest)
- Post-CPB vasoplegic syndrome: MAP under 65 despite fluid and catecholamines with a normal or high cardiac index and low SVR = NO-mediated vasoplegia → noradrenaline first, vasopressin 0.01-0.06 U/min, methylene blue 2 mg/kg IV for refractory
- ST elevation in the first hours post-CABG can be acute graft occlusion and warrants prompt investigation — urgent coronary angiography; do not write it off as pericarditis
- Postoperative AF in 20-40% with onset typically on days 2-4 (peak day 2) — rate control usually suffices; beta-blocker prophylaxis is the best-established prevention; balance anticoagulation against surgical bleeding
- Hypothermia on ICU arrival independently predicts bleeding leading to re-exploration — rewarm deliberately
- Methylene blue is contraindicated in G6PD deficiency and must be checked against SSRI or SNRI use (serotonin syndrome risk)
The one-paragraph exam answer
References34ShowHide
- [1]Datt V, Wadhhwa R, Sharma V, et al. Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management J Card Surg, 2021.PMID 34251716
- [2]Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, et al. Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial Anesthesiology, 2017.PMID 27841822
- [3]Chatterjee S, Ortoleva J, Arora RC, et al. Management Algorithm for Vasoplegic Shock After Cardiac Surgery: An Interdisciplinary Collaboration Ann Thorac Surg, 2026.PMID 42309294
- [4]Evora PR, Ribeiro PJ, Vicente WV, et al. Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties Rev Bras Cir Cardiovasc, 2009.PMID 20011872
- [5]Zhao CC, Zhai YJ, Hu ZJ, et al. Efficacy and safety of methylene blue in patients with vasodilatory shock: A systematic review and meta-analysis Front Med (Lausanne), 2022.PMID 36237547
- [6]McMillan E, Meepagala S, Ogbutor K, et al. Prevalence of Serotonergic Drug Use in Patients Exposed to Perioperative Methylene Blue: A Cross-Sectional Study Cureus, 2025.PMID 40271333
- [7]Youngster I, Arcavi L, Schechmaster R, et al. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review Drug Saf, 2010.PMID 20701405
- [8]Shou BL, Aravind P, Ong CS, et al. Early Reexploration for Bleeding Is Associated With Improved Outcome in Cardiac Surgery Ann Thorac Surg, 2023.PMID 35952856
- [9]Magruder JT, Belmustakov S, Ohkuma R, et al. Attributable harm of severe bleeding after cardiac surgery in hemodynamically stable patients Gen Thorac Cardiovasc Surg, 2017.PMID 27650660
- [10]Shou BL, Zhou AL, Ong CS, et al. Impact of intraoperative blood products, fluid administration, and persistent hypothermia on bleeding leading to reexploration after cardiac surgery J Thorac Cardiovasc Surg, 2024.PMID 37839660
- [11]Dyke C, Aronson S, Dietrich W, et al. Universal definition of perioperative bleeding in adult cardiac surgery J Thorac Cardiovasc Surg, 2014.PMID 24332097
- [12]Chuttani K, Tischler MD, Pandian NG, et al. Diagnosis of cardiac tamponade after cardiac surgery: relative value of clinical, echocardiographic, and hemodynamic signs Am Heart J, 1994.PMID 8154431
- [13]Russo AM, O'Connor WH, Waxman HL Atypical presentations and echocardiographic findings in patients with cardiac tamponade occurring early and late after cardiac surgery Chest, 1993.PMID 8325120
- [14]Leiva EH, Carreño M, Bucheli FR, et al. Factors associated with delayed cardiac tamponade after cardiac surgery Ann Card Anaesth, 2018.PMID 29652277
- [15]Dobrev D, Aguilar M, Heijman J, et al. Postoperative atrial fibrillation: mechanisms, manifestations and management Nat Rev Cardiol, 2019.PMID 30792496
- [16]Scherr K, Jensen L, Smith H, et al. Atrial fibrillation following cardiac surgery: a retrospective cohort series Prog Cardiovasc Nurs, 2006.PMID 16522963
- [17]Kim SH, Kim DW, Kim YH, et al. Perioperative Beta-Blocker for Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis Thorac Cardiovasc Surg, 2021.PMID 32252112
- [18]Turk T, Ata Y, Vural H, et al. Intravenous and oral amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing off-pump coronary artery bypass surgery Heart Surg Forum, 2007.PMID 17599879
- [19]Alghamdi AA, Al-Radi OO, Latter DA Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and meta-analysis J Card Surg, 2005.PMID 15854101
- [20]Imazio M, Belli R, Brucato A, et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial JAMA, 2014.PMID 25172965
- [21]Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial Circulation, 2005.PMID 16186437
- [22]Silvetti S, Paternoster G, Abelardo D, et al. Recommendations for fast-track extubation in adult cardiac surgery patients: a consensus statement Minerva Anestesiol, 2024.PMID 39545652
- [23]Mamoun NF, Lin P, Zimmerman NM, et al. Intravenous acetaminophen analgesia after cardiac surgery: A randomized, blinded, controlled superiority trial J Thorac Cardiovasc Surg, 2016.PMID 27236864
- [24]Rochon AG, Bélisle S, Couture P, et al. In Vivo Protamine Titration Using Activated Coagulation Time to Neutralize Heparin Anticoagulation in Cardiac Surgery: Proof of Concept J Cardiothorac Vasc Anesth, 2020.PMID 32014311
- [25]Meesters MI, Veerhoek D, de Lange F, et al. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial Thromb Haemost, 2016.PMID 27277211
- [26]Galeone A, Rotunno C, Guida P, et al. Monitoring incomplete heparin reversal and heparin rebound after cardiac surgery J Cardiothorac Vasc Anesth, 2013.PMID 23627997
- [27]Liu J, Birnbaum Y ST segment elevation following coronary artery bypass surgery J Electrocardiol, 2019.PMID 31629995
- [28]Kathiresan S, Servoss SJ, Newell JB, et al. Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality Am J Cardiol, 2004.PMID 15464669
- [29]Shroyer AL, Grover FL, Hattler B, et al. On-pump versus off-pump coronary-artery bypass surgery N Engl J Med, 2009.PMID 19890125
- [30]Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock N Engl J Med, 2012.PMID 22920912
- [31]Mehta RH, Leimberger JD, van Diepen S, et al. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery N Engl J Med, 2017.PMID 28316276
- [32]Nguyen LS, Squara P, Amour J, et al. Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial Crit Care, 2018.PMID 30115103
- [33]Lazar HL, Chipkin SR, Fitzgerald CA, et al. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events Circulation, 2004.PMID 15006999
- [34]Gayoso JM 5-year incidence of thrombocytosis and the effect on heparin dose response and heparin requirements J Extra Corpor Technol, 1999.PMID 10915475